Fenoprofen
| Clinical data | |
|---|---|
| Trade names | Nalfon |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a681026 |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Metabolism | Major urinary metabolites are fenoprofen glucuronide and 4′-hydroxyfenoprofen glucuronide. |
| Elimination half-life | 3 hours |
| Excretion | Renal (~90%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.046.213 100.045.231, 100.046.213 |
| Chemical and physical data | |
| Formula | C15H14O3 |
| Molar mass | 242.274 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Fenoprofen, sold under the brand name Nalfon among others, is a nonsteroidal anti-inflammatory drug (NSAID). Fenoprofen calcium is used for symptomatic relief for rheumatoid arthritis, osteoarthritis, and mild to moderate pain. It has also been used to treat postoperative pain. It is available as a generic medication.